Quest Analytics, Arcadia partner to build competitive networks
At AHIP 2025 in Las Vegas this week, Quest Analytics and Arcadia announced a data integration partnership that is expected to…
Federal judge orders grants terminated by NIH be restored
A federal court in Massachusetts has struck down the National Institutes of Health‘s decision to cancel grants that fund biomedical…
Augmented reality glasses give surgeons X-ray vision
Intraoperative 3D scans can be projected to the surgeon’s eyes to align to pre-op imaging, says Nissan Elimelech, founder of…
Senate Finance Committee releases its version of ‘Big Beautiful Bill’
Senate Finance Committee Chairman Mike Crapo, R-Idaho, on Monday released the committee’s version of President Donald Trump’s “Big Beautiful Bill.” …
Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor
This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20,…
High Response Rates With Talquetamab Plus Teclistamab in Triple-Class Refractory Multiple Myeloma
Talquetamab and teclistamab showed significant promise in a phase 1b/2 dose escalation and expansion trial.
Impact of a Community-Based Specialty Pharmacist in Identifying Drug Therapy Problems for New Adult Oncology Patients
This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20,…
Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis
Nemolizumab shows promising long-term efficacy in reducing itch and skin lesions for atopic dermatitis, enhancing quality of life for patients.
FDA Approves Ustekinumab-Stba, Biosimilar to Stelara, for Pediatric Patients With PsO or PsA
The subcutaneous infusion is indicated for pediatric patients aged 6 to 17 years who weigh less than 60 kg.